Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 441

4.

Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.

Logan YT, Belgeri MT.

Am J Geriatr Pharmacother. 2005 Jun;3(2):103-14. Review.

PMID:
16129387
6.

The role of combination medical therapy in benign prostatic hyperplasia.

Greco KA, McVary KT.

Int J Impot Res. 2008 Dec;20 Suppl 3:S33-43. doi: 10.1038/ijir.2008.51. Review.

PMID:
19002123
9.

A review of combination therapy in patients with benign prostatic hyperplasia.

McVary KT.

Clin Ther. 2007 Mar;29(3):387-98. Review.

PMID:
17577460
10.

Doxazosin controlled release vs tamsulosin in the management of benign prostatic hyperplasia: an efficacy analysis.

Kirby RS, Quinn S, Mallen S, Jensen D.

Int J Clin Pract. 2004 Jan;58(1):6-10.

PMID:
14994963
11.
13.
15.

After ALLHAT: doxazosin for the treatment of benign prostatic hyperplasia.

Doggrell SA.

Expert Opin Pharmacother. 2004 Sep;5(9):1957-64. Review.

PMID:
15330733
17.

Finasteride for benign prostatic hyperplasia.

Tacklind J, Fink HA, Macdonald R, Rutks I, Wilt TJ.

Cochrane Database Syst Rev. 2010 Oct 6;(10):CD006015. doi: 10.1002/14651858.CD006015.pub3. Review.

PMID:
20927745
20.

[Comparison of different drugs on the treatment of benign prostate hyperplasia].

Li NC, Wu SL, Jin J, Qiu SP, Kong CZ, Song YS, Ye ZQ, Sun G, Sun YH, Sun YC, Wang XF, Na YQ.

Zhonghua Wai Ke Za Zhi. 2007 Jul 15;45(14):947-50. Chinese.

PMID:
17961376
Items per page

Supplemental Content

Support Center